The offerings include in vitro assays to assess the immunogenic potential of test molecules using T cell activation and proliferation assays as a surrogate marker for the induction of Anti-Drug-Antibodies. On the immuno-oncology side, ImmunXperts develops in vitro assays to assess the functionality of candidates. ImmunXperts continuously develops new cellular immune-assays to assist biotech and pharma companies directly in their product development. Other such collaborative services include protocol optimization and in-house training.
ImmunXperts’ team works in an open-minded, science-driven and fast-paced environment. ImmunXperts has a unique knowledge in building custom assays that can be useful to cell therapy companies. We are a young company, but with rich history.
Our focus: In Vitro Immunology in a R&D context but at the highest level of quality
From January 2024: a brand new facility at the heart of Gosselies BioPark – with 850m² dedicated laboratory space (BSL2).
A growing dynamic team with various profiles. Over 70 customers in every corner of the globe (25 countries, and counting), from start-ups to big pharmas.
